Artículos de revistas sobre el tema "Glioma Stem-like Cells"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Glioma Stem-like Cells".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ventosa, Maria, Padma Kadiyala, Stephen Carney, Maria Castro y Pedro Lowenstein. "GENE-32. SYNTHETIC LETHAL INTERACTIONS WITH IDH1R132H IN GLIOMA STEM-LIKE CELLS". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi104. http://dx.doi.org/10.1093/neuonc/noz175.434.
Texto completoNikitin, Pavel V., Guzel R. Musina, Stanislav I. Pekov, Andrey A. Kuzin, Igor A. Popov, Artem Y. Belyaev, Gregory L. Kobyakov, Dmitry Y. Usachev, Viktor N. Nikolaev y Valentin P. Mikhailov. "Cell-Population Dynamics in Diffuse Gliomas during Gliomagenesis and Its Impact on Patient Survival". Cancers 15, n.º 1 (26 de diciembre de 2022): 145. http://dx.doi.org/10.3390/cancers15010145.
Texto completoBota, Daniela A., Daniela Alexandru, Stephen T. Keir, Darell Bigner, James Vredenburgh y Henry S. Friedman. "Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis". Journal of Neurosurgery 119, n.º 6 (diciembre de 2013): 1415–23. http://dx.doi.org/10.3171/2013.7.jns1323.
Texto completoKim, Jun-Kyum, Hye-Min Jeon, Hee-Young Jeon, Se-Yeong Oh, Eun-Jung Kim, Xiong Jin, Se-Hoon Kim, Sung-Hak Kim, Xun Jin y Hyunggee Kim. "Conversion of glioma cells to glioma stem-like cells by angiocrine factors". Biochemical and Biophysical Research Communications 496, n.º 4 (febrero de 2018): 1013–18. http://dx.doi.org/10.1016/j.bbrc.2017.02.076.
Texto completoAnand, Sumyuktha V., Alexander G. Skorput, Allan T. Gulledge, Isabella B. Fox, Damian A. Bonnin, Alison L. Young y Matthew C. Havrda. "Abstract 905: Targeting muscarinic acetylcholine receptors in glioma stem like cells". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 905. http://dx.doi.org/10.1158/1538-7445.am2022-905.
Texto completoJadus, Martin, Neil Hoa, Lisheng Ge, Yurii Kuznetsov, Alex McPherson, Andrew Cornforth, Nabil Ahmed y Lawrence Lamb. "Gliomas display complex cell surface topographies that resist cytolytic lymphocytes but are reversed by using fascin siRNA (48.2)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 48.2. http://dx.doi.org/10.4049/jimmunol.186.supp.48.2.
Texto completoFENG, XING, QIN ZHOU, CHONG LIU y MEI-LING TAO. "Drug screening study using glioma stem-like cells". Molecular Medicine Reports 6, n.º 5 (20 de agosto de 2012): 1117–20. http://dx.doi.org/10.3892/mmr.2012.1040.
Texto completoPersson, Anders I. y William A. Weiss. "The Side Story of Stem-like Glioma Cells". Cell Stem Cell 4, n.º 3 (marzo de 2009): 191–92. http://dx.doi.org/10.1016/j.stem.2009.02.004.
Texto completoLichti, Cheryl F., Norelle C. Wildburger, Alexander S. Shavkunov, Ekaterina Mostovenko, Huiling Liu, Erik P. Sulman y Carol L. Nilsson. "The proteomic landscape of glioma stem-like cells". EuPA Open Proteomics 8 (septiembre de 2015): 85–93. http://dx.doi.org/10.1016/j.euprot.2015.06.008.
Texto completoBerglar, Inka, Stephanie Hehlgans, Andrej Wehle, Caterina Roth, Christel Herold-Mende, Franz Rödel, Donat Kögel y Benedikt Linder. "CHRDL1 Regulates Stemness in Glioma Stem-like Cells". Cells 11, n.º 23 (3 de diciembre de 2022): 3917. http://dx.doi.org/10.3390/cells11233917.
Texto completoRao, Aparna, Xiaoran Zhang, Christopher Deibert, Paola Sette, Paola Grandi y Nduka Amankulor. "IDH Mutant Gliomas Escape Natural Killer Cell Immune Surveillance by Downregulation of NKG2D Ligand Expression". Journal of Immunology 196, n.º 1_Supplement (1 de mayo de 2016): 142.11. http://dx.doi.org/10.4049/jimmunol.196.supp.142.11.
Texto completoMandal, Ayan S., Rafael Romero-Garcia, Michael G. Hart y John Suckling. "Genetic, cellular, and connectomic characterization of the brain regions commonly plagued by glioma". Brain 143, n.º 11 (noviembre de 2020): 3294–307. http://dx.doi.org/10.1093/brain/awaa277.
Texto completoRichard, Seidu A. y Kuugbee D. Eugene. "The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials". Analytical Cellular Pathology 2021 (27 de octubre de 2021): 1–15. http://dx.doi.org/10.1155/2021/4907167.
Texto completoMandal, Ayan, Rafael Romero-Garcia, Michael Hart y John Suckling. "NIMG-13. GENETIC, CELLULAR, AND CONNECTOMIC CHARACTERIZATION OF THE ADULT HUMAN BRAIN REGIONS COMMONLY PLAGUED BY GLIOMA". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii149. http://dx.doi.org/10.1093/neuonc/noaa215.626.
Texto completoFan, Yipu, Weikang Xue, Melitta Schachner y Weijiang Zhao. "Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells Via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor". Cancers 11, n.º 1 (26 de diciembre de 2018): 22. http://dx.doi.org/10.3390/cancers11010022.
Texto completoPantazopoulou, Vasiliki, Tracy Berg y Alexander Pietras. "TAMI-71. EFFECTS OF THE TREATED MICROENVIRONMENT ON GLIOMA CELL PROPERTIES IN AN ORGANOTYPIC BRAIN SLICE MODEL". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi213. http://dx.doi.org/10.1093/neuonc/noab196.853.
Texto completoYu, Jennifer. "STEM-26. HYPOXIA REGULATES NOTCH TURNOVER IN GLIOMA STEM-LIKE CELLS". Neuro-Oncology 19, suppl_6 (noviembre de 2017): vi231. http://dx.doi.org/10.1093/neuonc/nox168.941.
Texto completoLo Cascio, Costanza, James McNamara, Ernesto Luna Melendez y Shwetal Mehta. "STEM-25. HDAC1 IS ESSENTIAL FOR GLIOMA STEM CELL SURVIVAL". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi239. http://dx.doi.org/10.1093/neuonc/noz175.998.
Texto completoYAMAMURO, SHUN, YUTAKA OKAMOTO, EMIKO SANO, YUSHI OCHIAI, AKIYOSHI OGINO, TAKASHI OHTA, HIROYUKI HARA et al. "Characterization of glioma stem-like cells from human glioblastomas". International Journal of Oncology 47, n.º 1 (7 de mayo de 2015): 91–96. http://dx.doi.org/10.3892/ijo.2015.2992.
Texto completoKang, Mi-Kyung y Soo-Kyung Kang. "Chemotherapeutic Drug Resistant Cancer Stem-like Cells of Glioma". Journal of Life Science 17, n.º 8 (30 de agosto de 2007): 1039–45. http://dx.doi.org/10.5352/jls.2007.17.8.1039.
Texto completoNayak, Sonali, Ashorne Mahenthiran, Yongyong Yang, Mark McClendon, Barbara Mania-Farnell, Charles David James, John A. Kessler et al. "Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application". Cancers 12, n.º 2 (24 de febrero de 2020): 516. http://dx.doi.org/10.3390/cancers12020516.
Texto completoXu, Zhong-Ye, Xiao-Qing Li, Song Chen, Yuan Cheng, Jin-Mu Deng y Zhi-Gang Wang. "Glioma Stem-like Cells are Less Susceptible than Glioma Cells to Sonodynamic Therapy with Photofrin". Technology in Cancer Research & Treatment 11, n.º 6 (diciembre de 2012): 615–23. http://dx.doi.org/10.7785/tcrt.2012.500277.
Texto completoD’Amico, Maria y Francesca De Amicis. "Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance". Cancer Drug Resistance 5 (2022): 939–53. http://dx.doi.org/10.20517/cdr.2022.46.
Texto completoXI, Guifa, Ashorne Mahenthiran, Benjamin Best, Sonali Nayak, Cara Smith, Mark McClendon, Barbara Mania-Farnell et al. "EXTH-18. PEPTIDE NANO-STRUCTURES ENHANCE PEDIATRIC BRAIN TUMOR CHEMOTHERAPEUTIC EFFICACY". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi86. http://dx.doi.org/10.1093/neuonc/noz175.352.
Texto completoMansour, Moustafa A., Masum Rahman, Ahmad A. Ayad, Arthur E. Warrington y Terry C. Burns. "P21 Overexpression Promotes Cell Death and Induces Senescence in Human Glioblastoma". Cancers 15, n.º 4 (17 de febrero de 2023): 1279. http://dx.doi.org/10.3390/cancers15041279.
Texto completoShirakawa, Yuki, Kunimasa Ohta, Shunsuke Miyake, Ayumi Kanemaru, Akari Kuwano, Kou Yonemaru, Shota Uchino et al. "Glioma Cells Acquire Stem-like Characters by Extrinsic Ribosome Stimuli". Cells 10, n.º 11 (1 de noviembre de 2021): 2970. http://dx.doi.org/10.3390/cells10112970.
Texto completoHede, Sanna-Maria, Inga Nazarenko, Monica Nistér y Mikael S. Lindström. "Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors". Journal of Oncology 2011 (2011): 1–11. http://dx.doi.org/10.1155/2011/852970.
Texto completoZHU, JIANHONG, HANDONG WANG, XIANGJUN JI, LIN ZHU, QING SUN, ZIXIANG CONG, YUAN ZHOU, HUANDONG LIU y MENGLIANG ZHOU. "Differential Nrf2 expression between glioma stem cells and non-stem-like cells in glioblastoma". Oncology Letters 7, n.º 3 (16 de diciembre de 2013): 693–98. http://dx.doi.org/10.3892/ol.2013.1760.
Texto completoYounis, Muhammad, Wang Faming, Zhao Hongyan, Tan Mengmeng, Song Hang y Yuan Liudi. "Iguratimod encapsulated PLGA-NPs improves therapeutic outcome in glioma, glioma stem-like cells and temozolomide resistant glioma cells". Nanomedicine: Nanotechnology, Biology and Medicine 22 (noviembre de 2019): 102101. http://dx.doi.org/10.1016/j.nano.2019.102101.
Texto completoPanditharatna, Eshini, Joana G. Marques, Tingjian Wang, Maria Trissal, Ilon Liu, Li Jiang, Alexander Beck et al. "DIPG-19. BAF COMPLEX PERTURBATION AS A NOVEL THERAPEUTIC OPPORTUNITY IN H3K27M PEDIATRIC GLIOMA". Neuro-Oncology 25, Supplement_1 (1 de junio de 2023): i16—i17. http://dx.doi.org/10.1093/neuonc/noad073.066.
Texto completoZHANG, SUOJUN, RUIFAN XIE, FENG WAN, FEI YE, DONGSHENG GUO y TING LEI. "Identification of U251 glioma stem cells and their heterogeneous stem-like phenotypes". Oncology Letters 6, n.º 6 (11 de octubre de 2013): 1649–55. http://dx.doi.org/10.3892/ol.2013.1623.
Texto completoMuthukrishnan, Sree Deepthi, Riki Kawaguchi, Pooja Nair, Alvaro Alvarado y Harley Kornblum. "Abstract B011: P300 histone acetyltransferase mediates glioma stem cell adaptive response to therapeutic stress". Cancer Research 82, n.º 10_Supplement (15 de mayo de 2022): B011. http://dx.doi.org/10.1158/1538-7445.evodyn22-b011.
Texto completoAnand, Sumyuktha V., Min K. Lee, Alexander G. Skorput, Isabella B. Fox, Alison L. Young, Brock C. Christensen, Allan Gulledge y Matthew C. Havrda. "Abstract 5801: Inhibition of muscarinic acetylcholine receptors in glioma stem cells blocks tumor progression". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5801. http://dx.doi.org/10.1158/1538-7445.am2023-5801.
Texto completoGaiti, Federico, Ronan Chaligne, Dana Silverbush, Joshua Schiffman, Hannah Weisman, lloyd Kluegel, Simon Gritsch et al. "EPCO-14. DECIPHERING DIFFERENTIATION HIERARCHIES, HERITABILITY AND PLASTICITY IN HUMAN GLIOMAS VIA SINGLE-CELL MULTI-OMICS". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii72. http://dx.doi.org/10.1093/neuonc/noaa215.293.
Texto completoCosta, Barbara, Tanja Eisemann, Jens Strelau, Ingrid Spaan, Andrey Korshunov, Hai-Kun Liu, Peter Bugert, Peter Angel y Heike Peterziel. "Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells". Blood Advances 3, n.º 7 (4 de abril de 2019): 1092–102. http://dx.doi.org/10.1182/bloodadvances.2018015966.
Texto completoTiburcio, Patricia, Mary Locke, Srivydia Bhaskara, Mahesh Chandrasekharan y Eric Huang. "STEM-25. DIFFERENTIAL REGULATION OF GLIOMA STEM-CELL MARKER NESTIN AND CD24 IN IDH-MUTANT GLIOMA". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii201. http://dx.doi.org/10.1093/neuonc/noaa215.842.
Texto completoParajuli, Prahlad, Mouli Mandalaparty, Chaya Brodie, Lawrence Lum, Archana Thakur y Sandeep Mittal. "Role of Th17/IL-17 inflammatory axis in the progression of malignant gliomas (P2095)". Journal of Immunology 190, n.º 1_Supplement (1 de mayo de 2013): 170.4. http://dx.doi.org/10.4049/jimmunol.190.supp.170.4.
Texto completoSharma, Vivek, Deobrat Dixit, Sadashib Ghosh y Ellora Sen. "COX-2 regulates the proliferation of glioma stem like cells". Neurochemistry International 59, n.º 5 (octubre de 2011): 567–71. http://dx.doi.org/10.1016/j.neuint.2011.06.018.
Texto completoBrooks, Lucy J. y Simona Parrinello. "Vascular regulation of glioma stem-like cells: a balancing act". Current Opinion in Neurobiology 47 (diciembre de 2017): 8–15. http://dx.doi.org/10.1016/j.conb.2017.06.008.
Texto completoShirakawa, Yuki, Takuichiro Hide, Michiko Yamaoka, Yuki Ito, Naofumi Ito, Kunimasa Ohta, Naoki Shinojima, Akitake Mukasa, Hideyuki Saito y Hirofumi Jono. "Ribosomal protein S6 promotes stem‐like characters in glioma cells". Cancer Science 111, n.º 6 (30 de abril de 2020): 2041–51. http://dx.doi.org/10.1111/cas.14399.
Texto completoCampos, Benito, Feng Wan, Mohammad Farhadi, Aurélie Ernst, Felix Zeppernick, Katrin E. Tagscherer, Rezvan Ahmadi et al. "Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells". Clinical Cancer Research 16, n.º 10 (4 de mayo de 2010): 2715–28. http://dx.doi.org/10.1158/1078-0432.ccr-09-1800.
Texto completoFigueroa, Javier, Lynette M. Phillips, Tal Shahar, Anwar Hossain, Joy Gumin, Hoon Kim, Andrew J. Bean et al. "Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587". Cancer Research 77, n.º 21 (30 de agosto de 2017): 5808–19. http://dx.doi.org/10.1158/0008-5472.can-16-2524.
Texto completoIsokpehi, Raphael D., Katharina C. Wollenberg Valero, Barbara E. Graham, Maricica Pacurari, Jennifer N. Sims, Udensi K. Udensi y Kenneth Ndebele. "Secondary Data Analytics of Aquaporin Expression Levels in Glioblastoma Stem-Like Cells". Cancer Informatics 14 (enero de 2015): CIN.S22058. http://dx.doi.org/10.4137/cin.s22058.
Texto completoJohnson, Kevin, Kevin Anderson, Djamel Nehar-Belaid, Frederick Varn, Amit Gujar, Elise Courtois, Paul Robson et al. "EPCO-13. IDENTIFYING REGULATORS OF GLIOMA CELL STATE DIVERSITY AND EVOLUTION VIA JOINT SINGLE NUCLEUS RNA AND CHROMATIN ACCESSIBILITY". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii118. http://dx.doi.org/10.1093/neuonc/noac209.448.
Texto completoSuresh, Rahul, Sophie Fiola, Jamie Beaulieu y Roberto Diaz. "PATH-14. ALPHA CARDIAC ACTIN EXPRESSION IS OBSERVED IN AGGRESSIVE GLIOMA SUBTYPES AND GLIOBLASTOMA STEM CELLS". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi117. http://dx.doi.org/10.1093/neuonc/noab196.466.
Texto completoGong, X., P. H. Schwartz, M. E. Linskey y D. A. Bota. "Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy". Neurology 76, n.º 13 (23 de febrero de 2011): 1126–34. http://dx.doi.org/10.1212/wnl.0b013e318212a89f.
Texto completoChamberlain, M. C., D. A. Bota, M. E. Linskey y P. H. Schwartz. "Neural Stem/Progenitors and Glioma Stem-Like Cells Have Differential Sensitivity to Chemotherapy". Neurology 77, n.º 22 (28 de noviembre de 2011): e135-e136. http://dx.doi.org/10.1212/wnl.0b013e318239ba7c.
Texto completoThomas, Jonathan G., Brittany C. Parker Kerrigan, Anwar Hossain, Joy Gumin, Naoki Shinojima, Felix Nwajei, Ravesanker Ezhilarasan, Patrice Love, Erik P. Sulman y Frederick F. Lang. "Ionizing radiation augments glioma tropism of mesenchymal stem cells". Journal of Neurosurgery 128, n.º 1 (enero de 2018): 287–95. http://dx.doi.org/10.3171/2016.9.jns16278.
Texto completoGorin, Fredric A., Nagarekha Pasupuleti, Dinesh Mahajan y Sundeep Dugar. "Killing Glioma ‘Stem-like’ Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins". Anti-Cancer Agents in Medicinal Chemistry 17, n.º 1 (enero de 2017): 40–47. http://dx.doi.org/10.2174/1871520616666160628122901.
Texto completoKONG, BYUNG HO, HYUN-DO SHIN, SE-HOON KIM, HYUN-SU MOK, JIN-KYOUNG SHIM, JI-HYUN LEE, HYE-JIN SHIN et al. "Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma". International Journal of Oncology 42, n.º 5 (12 de marzo de 2013): 1754–62. http://dx.doi.org/10.3892/ijo.2013.1856.
Texto completo